Earnings Summary

Genmab A/S’s revenue jumped 77.24% since last year same period to $1581Mn in the Q1 2021. On a quarterly growth basis, Genmab A/S has generated -22.65% fall in its revenue since last 3-months.

Genmab A/S’s net profit jumped 307.43% since last year same period to $1096Mn in the Q1 2021. On a quarterly growth basis, Genmab A/S has generated 88.64% jump in its net profits since last 3-months.

Genmab A/S’s net profit margin jumped 129.87% since last year same period to 69.32% in the Q1 2021. On a quarterly growth basis, Genmab A/S has generated 143.88% jump in its net profit margins since last 3-months.

Genmab A/S’s earning per share (EPS) estimates for the current quarter stand at 0.13 - a -64.13% fall from last quarter’s estimates.

Genmab A/S’s earning per share (EPS) estimates for the current year stand at 0.13.

Genmab A/S’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2023. This indicates that the Genmab A/S has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.